← Open Payments lookup

MARK HARVEY: Open Payments

NPI 1992947287 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,533 in 78 payments from 16 companies in 2025. Trend: 2023 $417 · 2024 $974 · 2025 $1,533

Food & beverage: $1,533
CompanyPaymentsAmount
ABBVIE INC.19$428
Otsuka America Pharmaceutical, Inc.13$212
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$186
Janssen Pharmaceuticals, Inc5$180
E.R. Squibb & Sons, L.L.C.11$154
JAZZ PHARMACEUTICALS INC.5$97
Teva Pharmaceuticals USA, Inc.3$62
Neurocrine BioSciences, Inc.3$52
Takeda Pharmaceuticals U.S.A., Inc.2$31
Tris Pharma Inc1$26

Products named: VRAYLAR, CAPLYTA, COBENFY, ABILIFY MAINTENA, SPRAVATO, REXULTI, XYWAV, UZEDY.

Industry payments across NE — which companies pay providers there.